|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
757511074 |
| 003 |
DE-627 |
| 005 |
20230905071929.0 |
| 007 |
tu |
| 008 |
130820s2014 xxu||||| 00| ||eng c |
| 010 |
|
|
|a 2013032339
|
| 020 |
|
|
|a 9789814472852
|c hardcover : alk. paper : 152,58
|9 978-981-4472-85-2
|
| 035 |
|
|
|a (DE-627)757511074
|
| 035 |
|
|
|a (DE-599)GBV757511074
|
| 035 |
|
|
|a (OCoLC)935104061
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XD-US
|c XA-GB
|c XB-SG
|
| 050 |
|
0 |
|a RS201.N35
|
| 060 |
|
0 |
|a QT 36.5
|
| 082 |
0 |
|
|a 615.3/99
|q LOC
|2 23
|
| 084 |
|
|
|a 15,3
|2 ssgn
|
| 084 |
|
|
|a XC 4000
|q HBZ
|2 rvk
|0 (DE-625)rvk/152514:12905
|
| 084 |
|
|
|a 58.28
|2 bkl
|
| 245 |
1 |
0 |
|a Selected topics in nanomedicine
|c ed. by Thomas Ming Swi Chang
|
| 264 |
|
1 |
|a New Jersey, NJ [u.a.]
|b World Scientific
|c 2014
|
| 300 |
|
|
|a VIII, 590 S.
|b Ill., graph. Darst.
|c 24 cm
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Regenerative medicine, artificial cells, and nanomedicine
|v 3
|
| 500 |
|
|
|a Includes bibliographical references and index
|
| 505 |
8 |
0 |
|t Artificial cells : the beginning of nanomedicine
|r Thomas Ming Swi ChangThe clinical development of hemopure(r) : a selective commentary / A. Gerson Greenburg
|
| 505 |
8 |
0 |
|t Glutaraldehyde polymerized porcine hemoglobin : preparation, safety evaluation and pharmacodynamics study
|r Chao Chen, Hongli Zhu and Kunping Yan
|
| 505 |
8 |
0 |
|t Evidence regarding some pharmacologic characteristics of hemoglobin-based oxygen carriers
|r Enrico Bucci
|
| 505 |
8 |
0 |
|t EAF PEG hemoglobins : novel class of nonhypertensive resuscitation fluids : simplicity and advantages of extension arm chemistry for PEGylation
|r Seetharama A. Acharya, Amy G. Tsai and Marcos Intaglietta
|
| 505 |
8 |
0 |
|t Biocompatibility of a highly concentrated fluid of hemoglobin-vesicles as a transfusion alternative
|r Hiromi Sakai
|
| 505 |
8 |
0 |
|t Molecular basis of haptoglobin and hemoglobin complex formation and protection against oxidative stress and damage
|r Yiping Jia and Abdu I. Alayash
|
| 505 |
8 |
0 |
|t Polynitroxylated hemoglobin as a multifunctional therapeutic for critical care and transfusion medicine
|r Li Ma and Carleton Jen Chang Hsia
|
| 505 |
8 |
0 |
|t Surface-mediated drug delivery
|r Benjamin M. Wohl, Betina Fejerskov,Siow-Feng Chong and Alexander N. Zelikin
|
| 505 |
8 |
0 |
|t Use of tunable pores for accurate characterization of micro- and nanoparticle systems in nanomedicine
|r James Eldridge, Aaron H. Colby, Geoff R. Willmott, Sam Yu and Mark W. Grinstaff
|
| 505 |
8 |
0 |
|t Microfluidic probes to process surfaces, cells, and tissues
|r Mohammad A. Qasaimeh, Sebastien G. Ricoult and David Juncker
|
| 505 |
8 |
0 |
|t Subcompartmentalized systems toward therapeutic cell mimics
|r Leticia Hosta-Rigau and Brigitte Stadler
|
| 505 |
8 |
0 |
|t Soft magnetic nanomaterials towards nanomedicine : magnetism principles, preparation, characterization and potential applications
|r G. W. Qin, S. Li, Y. P. Ren, F. Darain and K. Dimitrov
|
| 505 |
8 |
0 |
|t GoldMag composite particles and their applications in nanomedicine
|r Mingli Peng, Xu Chao, Chao Chen and Yali Cui
|
| 505 |
8 |
0 |
|t Nanoparticles for imaging and therapy : functionalization, endocytosis and characterization
|r Yu Zhang, Yi Li, Gurer Budak, Mihrimah Ozkan and Cengiz S. Ozkan
|
| 505 |
8 |
0 |
|t Noscapines : novel carrier systems to target tumor cells
|r Ramesh Chandra, J. Madan, Prashant Singh, Pradeep Kumar, V. Tomar, Sujata K. Dass and Ankush Chandra
|
| 505 |
8 |
0 |
|t High-throughput methods for miniaturization of implantable artificial cells
|r Maryam Mobed-Miremadi
|
| 505 |
8 |
0 |
|t Amphiphilic core-shell nanoparticles containing hairy polyethyleneimine shells as effective nanocarriers for gene delivery
|r Pei Li, Yuen Shan Siu, Kin Man Ho and Wei Li
|
| 505 |
8 |
0 |
|t Nano-chaperones : nanoparticles acting as artificial chaperones
|r S. Boridy and D. Maysinger
|
| 505 |
8 |
0 |
|t Bio-functional polymer vesicles for applications in nanomedicine
|r Hans-Peter M. de Hoog, Bo Liedberg and Madhavan Nallani
|
| 505 |
8 |
0 |
|t Carbon nanotubes in cancer and stem cell therapeutics
|r Wei Shao, Arghya Paul and Satya Prakash
|
| 505 |
8 |
0 |
|t Chitosan-based nanocarriers for efficient and targeted siRNA delivery
|r Surendra Nimesh and Ramesh Chandra
|
| 505 |
8 |
0 |
|t Application of polyethylenimine-based nanoparticles for RNA therapeutics
|r Surendra Nimesh and Ramesh Chandra
|
| 505 |
8 |
0 |
|t Nanosilver system technology for applications in nanomedicine
|r Helmut Schmid.
|
| 520 |
|
|
|a Artificial cells : the beginning of nanomedicine / Thomas Ming Swi Chang -- The clinical development of hemopure(r) : a selective commentary / A. Gerson Greenburg -- Glutaraldehyde polymerized porcine hemoglobin : preparation, safety evaluation and pharmacodynamics study / Chao Chen, Hongli Zhu and Kunping Yan -- Evidence regarding some pharmacologic characteristics of hemoglobin-based oxygen carriers / Enrico Bucci -- EAF PEG hemoglobins : novel class of nonhypertensive resuscitation fluids : simplicity and advantages of extension arm chemistry for PEGylation / Seetharama A. Acharya, Amy G. Tsai and Marcos Intaglietta -- Biocompatibility of a highly concentrated fluid of hemoglobin-vesicles as a transfusion alternative / Hiromi Sakai -- Molecular basis of haptoglobin and hemoglobin complex formation and protection against oxidative stress and damage / Yiping Jia and Abdu I. Alayash -- Polynitroxylated hemoglobin as a multifunctional therapeutic for critical care and transfusion medicine / Li Ma and Carleton Jen Chang Hsia -- Surface-mediated drug delivery / Benjamin M. Wohl, Betina Fejerskov,Siow-Feng Chong and Alexander N. Zelikin -- Use of tunable pores for accurate characterization of micro- and nanoparticle systems in nanomedicine / James Eldridge, Aaron H. Colby, Geoff R. Willmott, Sam Yu and Mark W. Grinstaff -- Microfluidic probes to process surfaces, cells, and tissues / Mohammad A. Qasaimeh, Sebastien G. Ricoult and David Juncker -- Subcompartmentalized systems toward therapeutic cell mimics / Leticia Hosta-Rigau and Brigitte Stadler -- Soft magnetic nanomaterials towards nanomedicine : magnetism principles, preparation, characterization and potential applications / G. W. Qin, S. Li, Y. P. Ren, F. Darain and K. Dimitrov -- GoldMag composite particles and their applications in nanomedicine / Mingli Peng, Xu Chao, Chao Chen and Yali Cui -- Nanoparticles for imaging and therapy : functionalization, endocytosis and characterization / Yu Zhang, Yi Li, Gurer Budak, Mihrimah Ozkan and Cengiz S. Ozkan -- Noscapines : novel carrier systems to target tumor cells / Ramesh Chandra, J. Madan, Prashant Singh, Pradeep Kumar, V. Tomar, Sujata K. Dass and Ankush Chandra -- High-throughput methods for miniaturization of implantable artificial cells / Maryam Mobed-Miremadi -- Amphiphilic core-shell nanoparticles containing hairy polyethyleneimine shells as effective nanocarriers for gene delivery / Pei Li, Yuen Shan Siu, Kin Man Ho and Wei Li -- Nano-chaperones : nanoparticles acting as artificial chaperones / S. Boridy and D. Maysinger -- Bio-functional polymer vesicles for applications in nanomedicine / Hans-Peter M. de Hoog, Bo Liedberg and Madhavan Nallani -- Carbon nanotubes in cancer and stem cell therapeutics / Wei Shao, Arghya Paul and Satya Prakash -- Chitosan-based nanocarriers for efficient and targeted siRNA delivery / Surendra Nimesh and Ramesh Chandra -- Application of polyethylenimine-based nanoparticles for RNA therapeutics / Surendra Nimesh and Ramesh Chandra -- Nanosilver system technology for applications in nanomedicine / Helmut Schmid
|
| 650 |
|
2 |
|a Nanomedicine
|x methods
|
| 650 |
|
2 |
|a Nanostructures
|x therapeutic use
|
| 650 |
|
2 |
|a Artificial Cells
|
| 650 |
|
2 |
|a Blood Substitutes
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4045699-7
|0 (DE-627)104162406
|0 (DE-576)209066407
|a Pharmazeutische Technologie
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4342626-8
|0 (DE-627)153672439
|0 (DE-576)211436038
|a Nanostrukturiertes Material
|2 gnd
|
| 689 |
0 |
2 |
|D s
|0 (DE-588)4333369-2
|0 (DE-627)148058310
|0 (DE-576)211339695
|a Nanopartikel
|2 gnd
|
| 689 |
0 |
3 |
|D s
|0 (DE-588)1067838503
|0 (DE-627)819251739
|0 (DE-576)426982746
|a Nanomedizin
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 700 |
1 |
|
|a Chang, Thomas Ming Swi
|4 oth
|
| 830 |
|
0 |
|a Regenerative medicine, artificial cells and nanomedicine
|v 3
|9 3
|w (DE-627)539547506
|w (DE-576)290211492
|w (DE-600)2382086-X
|7 ns
|
| 856 |
4 |
2 |
|u http://www.gbv.de/dms/bowker/toc/9789814472852.pdf
|m V:DE-601
|m X:Bowker
|q pdf/application
|v 2014-03-19
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a ISIL_DE-18
|
| 912 |
|
|
|a GBV_ILN_22_i04712
|
| 936 |
r |
v |
|a XC 4000
|b Allgemeines
|k Medizin
|k Allgemeine Medizin, Krankenhauswesen, Krankenpflege
|k Medizin und Naturwissenschaften
|k Medizin und Technik, Biomedizinische Technik
|k Allgemeines
|0 (DE-627)1271081768
|0 (DE-625)rvk/152514:12905
|0 (DE-576)201081768
|
| 936 |
b |
k |
|a 58.28
|j Pharmazeutische Technologie
|0 (DE-627)106417622
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 615.3/99
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 1463885474
|c 00
|f --%%--
|d 2931-9756
|e --%%--
|j --%%--
|y k
|z 22-04-14
|
| 980 |
|
|
|2 22
|1 01
|x 0018
|b 1523366826
|c 00
|f 18/47-p
|d 87.60 Sel
|e i
|j --%%--
|y zi04712
|z 19-03-15
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$029319756
|
| 984 |
|
|
|2 22
|1 01
|x 0018
|a 104843080
|
| 985 |
|
|
|2 22
|1 01
|x 0018
|a 2015.163
|
